Deb Blake-Ontiveros: Bringing Her Voice to Motherhood, Advocacy, and Breast Cancer


Deb Blake-Ontiveros

A lot of the time a cancer survivor’s story goes: “I felt a lump in my breast, I got it checked out, and it was breast cancer.” That’s not the story of Deb Blake-Ontiveros. The single mother visited a doctor after she felt a lump in her breast. But her doctor dismissed it as something else. Two years passed before Deb was diagnosed with breast cancer. “If we go back in time ... and I would have been maybe a little bit less distracted with the baby and more like, ‘Hey, I think I would like further screening’ that could have been the change there. But that's the reality, though,” Deb told Salud America! That reality is that some women with breast cancer, especially young Latinas whose symptoms often go ignored or misdiagnosed, never get to ring the bell. For Deb, ...

Read More

Salud Talks Podcast Episode 48: Road to Survivorship: Understanding Innovations in Breast Cancer Diagnoses


natera podcast with saludtalks salud america amelie ramirez

As we celebrate Breast Cancer Awareness Month in October, Salud America! is having important conversations about how breast cancer trends impact communities and populations in South Texas and beyond. Breast cancer is the most common cancer diagnosed in Latinas and top cause of cancer-related death among Latinas. With this in mind, Salud America!’s Salud Talks Podcast collaborated with Dr. Marcela Mazo Canola, breast medical oncologist at the Mays Cancer Center at UT Health San Antonio, and Dr. Angel Rodriguez, senior medical director of oncology for Natera, to discuss new technologies to care for people who have been diagnosed with breast cancer. This episode is hosted by Dr. Amelie G. Ramirez, director of the Institute for Health Promotion Research at UT Health San ...

Read More

8 Things to Know About Latina Breast Cancer


brunette latin adult woman, showing the pink ribbon that she wears on her chest as a symbol of the fight against cancer

Breast cancer is the leading cause of cancer-related deaths in Latinas.   Despite advances in prevention and treatment, Latina breast cancer continues to be detected at advanced stages when the prognosis isn’t optimistic.   There are several contributing factors to why Latinas face worse outcomes when it comes to breast cancer.  October is Breast Cancer Awareness Month, and to honor all who have been impacted by the disease, we are discussing the top eight things to know about Latina breast cancer.   1. Latina Breast Cancer Diagnosis Breast cancer is the most common cancer among Latinas, impacting U.S. Latinas at a rate of 106.6 per 100,000 people, according to the American Cancer Society’s 2026 Cancer Facts & Figures report.   This equates to roughly 1 out ...

Read More

Training Latino Cancer Researchers with the Éxito! Program at the IHPR at UT Health San Antonio


IHPR 20 - Exito Success Photo 4

Latinos are not proportionally represented in research, nursing, and doctoral fields, even though they make up 20% of the U.S. population. The Éxito! program aimed to fill that gap. Éxito!, created by Dr. Amelie G. Ramirez of the Institute for Health Promotion Research (IHPR) at UT Health San Antonio, recruited 226 students and health professionals over 11 years for a culturally tailored curriculum to promote pursuit of a doctoral degree and Latino cancer research career. With the 20th anniversary of the IHPR on Oct. 1, 2026, now is a good time to check in and see some Éxito! trainees have progressed! About the Éxito! Program at the IHPR Each year from 2011 to 2021, the IHPR’s Éxito! program hosted a five-day summer institute in San Antonio, Texas. The event ...

Read More

El Doble Espejo de Septiembre: Un Mensaje de Esperanza y Fortaleza para Nuestra Comunidad


Arnoldo Rodriguez

by Arnoldo Rodriguez Para la mayoría de las personas, septiembre es simplemente la frontera entre el verano y el otoño. Pero para quienes hemos sido tocados por el cáncer, es un mes de gran peso. Para mí, ese peso se duplica. Septiembre es a la vez el Mes de Concientización sobre el Cáncer de Próstata y el Mes de Concientización sobre el Cáncer de la Sangre.  Como sobreviviente tanto de cáncer de próstata como de linfoma folicular, este mes siempre llega con una compleja mezcla de emociones. Actúa como un doble espejo, obligándome a mirar atrás hacia las luchas distintas y agotadoras de dos diagnósticos completamente diferentes. Reaviva los fantasmas de ansiedades pasadas, el frío clínico de las salas de tratamiento y la profunda vulnerabilidad de ser paciente. Ese ...

Read More

The Double Mirror of September: A Message of Hope and Strength for Our Comunidad


Arnoldo Rodriguez

by Arnoldo Rodriguez For most people, September is simply the boundary between summer and autumn. But for those of us whose lives have been touched by cancer, it is a month of heavy significance. For me, that weight is doubled. September is both Prostate Cancer Awareness Month and Blood Cancer Awareness Month.  As a survivor of both prostate cancer and follicular lymphoma, this month always arrives with a complex rush of emotions. It acts as a double mirror, forcing me to look back at the distinct, grueling struggles of two entirely different diagnoses. It reawakens the ghosts of past anxieties, the clinical chill of treatment rooms, and the profound vulnerability of being a patient. That is the bitter side of September—the visceral reminder of what was endured.  If you are ...

Read More

Claudia Perez-Favela: Shattering Reproductive Cancer Stigmas and Challenges



For Claudia Perez-Favela, cancer has always been the elephant in the room.  Claudia has seen her Latino family members endure cancer and even perish from the disease over the years. Yet they never openly shared their experiences.  “In my family, cancer is like the flu,” she said.  Because cancer is such a taboo subject in her family, when Claudia got cervical cancer from the HPV virus, she couldn’t turn to her family for support.  “They are gonna say ... I got cancer because I did something wrong ... we don’t talk about cancer,” she said.   Instead of staying silent, Claudia shook off the stigma behind her diagnosis and started to share her story and challenge the harmful falsehoods behind HPV so women like her can stay informed against ...

Read More

Top Recommendations for Advancing Cancer Research for Latinos and All People


Advancing Cancer Research for Latinos and All Populations Conference ACRLP Cover art proceedings 2026 - new

With cancer still a top health threat, UT Health San Antonio leaders and national cancer experts have published an online book with innovative recommendations to reduce cancer among Latinos and all people. The book, “Advancing Cancer Research for Latinos and All Populations: 2026 Conference Proceedings,” highlights results of the same-named conference that brought 350 researchers, advocates, and survivors to San Antonio in February 2026. A follow-up conference is planned for Feb. 23-25, 2028, in San Antonio. Included in the book are promising research findings on Latino cancer and strategies for new research covering the entire cancer continuum. This includes advances in genetics, prevention, screening, detection, treatment, survivorship, and policy, said Dr. Amelie ...

Read More

Advancing Cancer Research for Latinos and All Populations: 2026 Conference Proceedings


ACRLP Conference Proceedings Images

Cancer is a threat to the health of Latinos and all people. That’s why Dr. Amelie Ramirez, director of Salud America! and the Institute for Health Promotion Research at UT Health San Antonio, partnered with the Mays Cancer Center to create the Advancing Cancer Research for Latinos and All Populations (ACRLP) biennial conference series. On Feb. 18-20, 2026, the newest ACRLP conference welcomed over 350 prominent researchers, physicians, healthcare professionals, patient advocates, and students from across the globe to address cancer among Latinos and all people in San Antonio, Texas. Conference sponsors included: Genentech, Bristol Myers Squibb, Gilead, Revolution Medicine, Natera, AstraZeneca (platinum); Blood Cancer United, Menarini Stemline, Eli Lilly (gold); National ...

Read More